207 related articles for article (PubMed ID: 32960848)
1. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
[TBL] [Abstract][Full Text] [Related]
2. Changes in Central Line-Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review.
Linder LA; Gerdy C; Jo Y; Wilson A
J Pediatr Oncol Nurs; 2018; 35(6):382-391. PubMed ID: 29665727
[TBL] [Abstract][Full Text] [Related]
3. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
[TBL] [Abstract][Full Text] [Related]
4. Central Venous Catheter Salvage in Ambulatory Central Line-Associated Bloodstream Infections.
Ford WJH; Bundy DG; Oyeku S; Heo M; Saiman L; Rosenberg RE; DeLaMora P; Rabin B; Zachariah P; Mirhaji P; Klein E; Obaro-Best O; Drasher M; Peshansky A; Rinke ML
Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814175
[TBL] [Abstract][Full Text] [Related]
5. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients.
Metzger KE; Rucker Y; Callaghan M; Churchill M; Jovanovic BD; Zembower TR; Bolon MK
Infect Control Hosp Epidemiol; 2015 Feb; 36(2):119-24. PubMed ID: 25632993
[TBL] [Abstract][Full Text] [Related]
6. The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.
Devrim İ; Sandal OS; Çelebi MY; Hepduman P; Gönüllü A; Atakul G; Kara AA; Oruç Y; Gülfidan G; Bayram N; Ağın H
Eur J Pediatr; 2023 Oct; 182(10):4625-4632. PubMed ID: 37555974
[TBL] [Abstract][Full Text] [Related]
7. Lower risk of bloodstream infections for peripherally inserted central catheters compared to central venous catheters in critically ill patients.
Pitiriga V; Bakalis J; Theodoridou K; Kanellopoulos P; Saroglou G; Tsakris A
Antimicrob Resist Infect Control; 2022 Nov; 11(1):137. PubMed ID: 36352414
[TBL] [Abstract][Full Text] [Related]
8. Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study.
Pitiriga V; Bakalis J; Kampos E; Kanellopoulos P; Saroglou G; Tsakris A
Antimicrob Resist Infect Control; 2022 Jul; 11(1):96. PubMed ID: 35841083
[TBL] [Abstract][Full Text] [Related]
9. Management of enterococcal central line-associated bloodstream infections in patients with cancer.
Awadh H; Chaftari AM; Khalil M; Fares J; Jiang Y; Deeba R; Ali S; Hachem R; Raad II
BMC Infect Dis; 2021 Jul; 21(1):643. PubMed ID: 34225651
[TBL] [Abstract][Full Text] [Related]
10. Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.
Kelada AS; Foster TB; Gagliano GC; Worley S; Tang A; Arakoni VA; Foster CB
Infect Control Hosp Epidemiol; 2023 Mar; 44(3):377-383. PubMed ID: 35475427
[TBL] [Abstract][Full Text] [Related]
11. Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013.
Epstein L; See I; Edwards JR; Magill SS; Thompson ND
Infect Control Hosp Epidemiol; 2016 Jan; 37(1):2-7. PubMed ID: 26456954
[TBL] [Abstract][Full Text] [Related]
12. Central line maintenance bundles and CLABSIs in ambulatory oncology patients.
Rinke ML; Bundy DG; Chen AR; Milstone AM; Colantuoni E; Pehar M; Herpst C; Fratino L; Miller MR
Pediatrics; 2013 Nov; 132(5):e1403-12. PubMed ID: 24101764
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Ambulatory Central Line-Associated Bloodstream Infections.
Rinke ML; Heo M; Saiman L; Bundy DG; Rosenberg RE; DeLaMora P; Rabin B; Zachariah P; Mirhaji P; Ford WJH; Obaro-Best O; Drasher M; Klein E; Peshansky A; Oyeku SO
Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33386333
[TBL] [Abstract][Full Text] [Related]
14. A Prospective, Holistic, Multicenter Approach to Tracking and Understanding Bloodstream Infections in Pediatric Hematology-Oncology Patients.
Gaur AH; Bundy DG; Werner EJ; Hord JD; Miller MR; Tang L; Lawlor JP; Billett AL;
Infect Control Hosp Epidemiol; 2017 Jun; 38(6):690-696. PubMed ID: 28399945
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Rates of Central Line-Associated Bloodstream Infections in Patients With 1 vs 2 Central Venous Catheters.
Dube WC; Jacob JT; Zheng Z; Huang Y; Robichaux C; Steinberg JP; Fridkin SK
JAMA Netw Open; 2020 Mar; 3(3):e200396. PubMed ID: 32129868
[TBL] [Abstract][Full Text] [Related]
16. Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
Chong CY; Ong RY; Seah VX; Tan NW; Chan MY; Soh SY; Ong C; Lim AS; Thoon KC
J Paediatr Child Health; 2020 Jan; 56(1):123-129. PubMed ID: 31145505
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of catheter-related bloodstream infections in haemato-oncology patients: comparison of two definitions.
de Mooij CEM; van der Velden WJFM; Verweij PE; de Haan AFJ; van Groningen LFJ; Meijer C; Hopman J; Blijlevens NMA
J Hosp Infect; 2020 Aug; 105(4):686-690. PubMed ID: 32339616
[TBL] [Abstract][Full Text] [Related]
18. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
[TBL] [Abstract][Full Text] [Related]
19. Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.
Kelly M; Conway M; Wirth K; Potter-Bynoe G; Billett AL; Sandora TJ
Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1079-85. PubMed ID: 22011534
[TBL] [Abstract][Full Text] [Related]
20. Preventive strategies for central line-associated bloodstream infections in pediatric hematopoietic stem cell transplant recipients.
Barrell C; Covington L; Bhatia M; Robison J; Patel S; Jacobson JS; Buet A; Graham PL; Saiman L
Am J Infect Control; 2012 Jun; 40(5):434-9. PubMed ID: 21907455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
